Advances in the management of primary central nervous system lymphoma.
Clin Adv Hematol Oncol
Biomarkers, Tumor; Central Nervous System Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Disease Management; Humans; Lymphoma, Non-Hodgkin; Mutation; Research Design; Standard of Care; Tumor Microenvironment
Dunleavy, K. (2017). Advances in the management of primary central nervous system lymphoma.. Clin Adv Hematol Oncol, 15 (9). Retrieved from https://hsrc.himmelfarb.gwu.edu/smhs_medicine_facpubs/1295